| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 105.16 mm | 105.16 mm | 105.16 mm | 105.16 mm | 105.16 mm | 105.16 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 1.96 mm | (no burn) | 10.54 mm | 3.46 mm |
| Cash used (since last report) | n/a | n/a | 7.07 mm | n/a | 38.09 mm | 12.52 mm |
| Cash remaining | n/a | n/a | 98.09 mm | n/a | 67.07 mm | 92.64 mm |
| Runway (months of cash) | n/a | n/a | 50.2 | n/a | 6.4 | 26.8 |
| 13F holders | Current |
|---|---|
| Total holders | 105 |
| Opened positions | 18 |
| Closed positions | 15 |
| Increased positions | 43 |
| Reduced positions | 24 |
| 13F shares | Current |
|---|---|
| Total value | 475.82 bn |
| Total shares | 40.40 mm |
| Total puts | 4.10 k |
| Total calls | 40.30 k |
| Total put/call ratio | 0.1 |
| Largest owners | Shares | Value |
|---|---|---|
| Baker Bros. Advisors | 4.87 mm | $84.13 bn |
| 5AM Venture Management | 4.41 mm | $76.22 bn |
| MPM Asset Management | 4.38 mm | $75.75 bn |
| 5AM Ventures V | 3.28 mm | $83.47 mm |
| T. Rowe Price | 2.90 mm | $50.19 mm |
| Roche Finance | 2.57 mm | $34.35 mm |
| MPM BioVentures 2014 | 2.21 mm | $56.38 mm |
| JHG Janus Henderson | 2.08 mm | $36.01 bn |
| BlackRock | 1.97 mm | $34.14 bn |
| MRL Ventures Fund | 1.74 mm | $29.79 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Apr 25 | Kory James Wentworth | Common Stock | Option exercise | Acquire M | No | No | 2.1 | 11,134 | 23.38 k | 120,670 |
| 3 Apr 25 | Kory James Wentworth | Stock Option Common Stock | Option exercise | Dispose M | No | No | 2.1 | 11,134 | 23.38 k | 20,023 |
| 17 Mar 25 | Kory James Wentworth | Common Stock | Sell | Dispose S | No | Yes | 10.67 | 1,784 | 19.04 k | 109,536 |
| 3 Mar 25 | Natarajan Sethuraman | Common Stock | Payment of exercise | Dispose F | No | No | 11.6786 | 6,138 | 71.68 k | 199,659 |
| 3 Mar 25 | Nathan J Dowden | Common Stock | Payment of exercise | Dispose F | No | No | 11.6786 | 5,144 | 60.07 k | 180,805 |
| 3 Mar 25 | Kory James Wentworth | Common Stock | Payment of exercise | Dispose F | No | No | 11.6786 | 4,929 | 57.56 k | 111,320 |
| 1 Mar 25 | Natarajan Sethuraman | Common Stock | Grant | Acquire A | No | No | 0 | 60,800 | 0.00 | 205,797 |
| 1 Mar 25 | Natarajan Sethuraman | Stock Option Common Stock | Grant | Acquire A | No | No | 11.94 | 90,800 | 1.08 mm | 90,800 |
| 1 Mar 25 | Nathan J Dowden | Common Stock | Grant | Acquire A | No | No | 0 | 60,800 | 0.00 | 185,949 |
| 1 Mar 25 | Nathan J Dowden | Stock Option Common Stock | Grant | Acquire A | No | No | 11.94 | 90,800 | 1.08 mm | 90,800 |
